Hanbing Zhang | Biological Sciences | Best Researcher Award | 13452

Assist Prof Dr. Hanbing Zhang | Biological Sciences | Best Researcher Award 

Assist Prof Dr. Hanbing Zhang, Dalian Ocean University, China

Dr. Hanbing Zhang, Associate Professor at Dalian Ocean University and Deputy Director of the Experimental Center, is a leading innovator in fisheries equipment and eco-efficient aquatic technologies. With over 20 SCI-indexed publications, 20 patents, and leadership in 14 national/provincial projects—including the Blue Granary sub-program—his research has significantly advanced mechanization and sustainability in Chinese aquaculture.

👩‍⚕️ Author Profile

Scopus

🎓 Early Academic Pursuits

From his formative academic years, Dr. Hanbing Zhang demonstrated a keen aptitude for applied sciences, particularly in the field of agricultural and fishery engineering. With a Ph.D. in an engineering-related discipline, he set the foundation for a research-intensive career by focusing on real-world applications for sustainable aquaculture. His early studies laid the groundwork for developing advanced fisheries equipment, which would later earn national and provincial acclaim.

🧪 Professional Endeavors and Research Leadership

Now serving as Associate Professor and Deputy Director of the Experimental Center at Dalian Ocean University, Dr. Zhang is a pioneering force in fishery technology and environmental innovation. His role encompasses academic teaching, laboratory development, and project leadership.

He has led or participated in 14 completed or ongoing research projects, many of which were funded by prestigious national grants, including contributions to China’s Blue Granary initiative, which supports sustainable seafood harvesting and production across the nation. These projects are not only significant in academic terms but also directly influence China’s aquatic food security strategy.

⚙️ Contributions and Research Focus

A standout element of Dr. Zhang’s work is his invention and optimization of mechanized fisheries systems, notably the:

  • BMJ-2 Mechanized Sower

  • BCJ-2 Ecological Harvester

These systems have been formally recognized by China’s Ministry of Agriculture and are currently in use across eight provinces, achieving a 45% reduction in operational costs — a remarkable feat in energy efficiency and operational scalability.

Dr. Zhang’s research spans:

  • Fishery equipment innovation

  • Marine and aquatic product processing

  • Energy-saving technologies in aquaculture

  • Emission-reduction systems in sustainable farming

These developments not only boost yield efficiency but also contribute to climate-conscious agriculture.

📚 Scientific Contributions and Publications

Dr. Zhang has published over 20 scientific papers, with 13 indexed in SCI and Scopus, contributing valuable data to the global research community on marine and aquatic systems. His work combines rigorous engineering models with ecological stewardship.

In addition, he holds an impressive 20 patents, including a wakame separation system that boasts 92% separation efficiency—a testament to his technical ingenuity.

His scholarly impact continues to rise, as evidenced by ongoing consultations in 14 industry-sponsored projects, where academia meets industrial implementation.

🏆 Accolades and Recognition

Dr. Zhang has received multiple provincial awards for both his scientific research and teaching excellence. These accolades underscore the dual strength of his profile—as both a cutting-edge researcher and a devoted academic mentor.

He is an active member of several professional societies:

  • China Agricultural Engineering Society

  • China Agricultural Machinery Society

  • China Fisheries Society

These memberships reflect his continued engagement with the broader scientific and agricultural technology communities.

🌏 Impact and Influence

What sets Dr. Zhang apart is his deep community and ecological impact. By integrating smart technologies into traditional aquaculture systems, he’s creating scalable models for environmentally sustainable fisheries.

His inventions are currently benefiting farmers across China, making their work more efficient, profitable, and ecologically safe. Through innovation, he empowers local economies and promotes low-carbon agriculture — a national and global priority.

🌟 Legacy and Future Contributions

As a trailblazer in eco-innovative fishery equipment, Dr. Hanbing Zhang is shaping the future of sustainable marine resource management. His ability to translate research into real-world solutions has not only improved productivity but also positioned him as a leader in marine technology.

Looking forward, Dr. Zhang aims to expand his research on:

  • Artificial intelligence integration in fishery automation

  • Carbon-neutral aquaculture technologies

  • Collaborative marine equipment networks across Asia-Pacific

These future endeavors will further his goal of making China a global leader in smart and sustainable fisheries.

📄Publication Top Notes


📄Biofouling Community Dynamics on Nylon and Polyethylene Aquaculture Nets in the North Yellow Sea: Colonization Patterns and Mytilus edulis Mechanical Properties

Author: S., He, Sai, Q., Xue, Qingsong, Z., Fu, Zhixuan, H., Zhang, Hanbing, T., Qiu, Tianlong

Journal: Water,

Year: 2025

Takeshi Chiba | Life Sciences | Best Researcher Award

Dr. Takeshi Chiba | Life Sciences | Best Researcher Award

Associate Professor at Juntendo University, Japan

Dr. Takeshi Chiba is an Associate Professor and Assistant Director at Juntendo University’s Laboratory of Clinical Pharmacology and Department of Pharmacy. He earned his pharmacist’s license in 1999 and a Ph.D. in Pharmaceutical Sciences in 2002 from Josai University. His professional journey includes roles at Iwate Medical University Hospital, Iwate Medical University, Hokkaido University of Science, and Juntendo University. Dr. Chiba’s research focuses on the physiological functions of mammary epithelial cells during lactation, including the synthesis of norepinephrine and the effects of psychological stress and smoking on milk composition. His contributions have led to significant findings in cell biology and pharmacology, reflected in 42 published journal articles and numerous awards. He is a member of several professional societies and has been recognized for his work with academic awards and publications.

Professional Profiles:

🎓 Education

Dr. Takeshi Chiba earned his Pharmacist’s license from Josai University in Saitama, Japan, in March 1999. He then pursued advanced studies at the same institution, culminating in a Ph.D. in Pharmaceutical Sciences, which he completed in March 2002.

Professional Experience

Dr. Takeshi Chiba began his career as a pharmacist at Iwate Medical University Hospital in Japan, serving from April 2002 to March 2009. He transitioned to an academic role as an Assistant Professor in the Department of Clinical Pharmaceutics at Iwate Medical University from April 2009 to March 2019. He then moved to Hokkaido University of Science, where he was a Lecturer in the Department of Clinical Pharmaceutics from April 2019 to March 2023. Since April 2023, Dr. Chiba has been serving as an Associate Professor in the Laboratory of Clinical Pharmacology at the Faculty of Pharmacy, Juntendo University, while also holding the position of Assistant Director at the Department of Pharmacy, Juntendo University Hospital.

Research Interest

Dr. Takeshi Chiba’s research interests focus on clinical pharmacology, particularly the physiological and biochemical aspects of lactation and its impact on infant health. His notable research includes the discovery that mammary epithelial cells synthesize and secrete norepinephrine into milk during lactation, a previously unknown function. He also investigates the effects of psychological stress on microRNA expression in milk, specifically how decreased miR-148a levels influence intestinal tight junction protein regulation in infants. Additionally, his research addresses how smoking affects milk composition by increasing miR-210 expression in mammary epithelium and its implications for infant nutrition and health.

Award and Honors

Dr. Takeshi Chiba has received notable recognition for his contributions to the field of clinical pharmacology. In June 2019, he was honored with an academic award from the Iwate Society of Hospital Pharmacists, reflecting his significant achievements and impact in his area of expertise.

Research Skills

Dr. Takeshi Chiba’s research skills encompass a diverse range of expertise in clinical pharmacology, nutrition, and cell biology. He is proficient in the analysis of physiological functions, including the synthesis and secretion of norepinephrine in mammary epithelial cells and the impact of psychological stress and smoking on milk composition. Dr. Chiba is adept at investigating the regulatory effects of microRNAs on tight junction proteins in infants’ intestines. His research methods involve a combination of experimental and analytical techniques to understand and innovate in the fields of pharmacology and health science.

Publications

  1. “Smoking-induced suppression of β-casein in milk is associated with an increase in miR-210-5p expression in mammary epithelia”
    • Authors: Chiba, T., Takaguri, A., Mikuma, T., Kimura, T., Maeda, T.
    • Year: 2024
  2. “Human Milk Exosomes Induce ZO-1 Expression via Inhibition of REDD1 Expression in Human Intestinal Epithelial Cells”
    • Authors: Chiba, T., Maeda, T.
    • Year: 2023
  3. “Suppression of milk-derived miR-148a caused by stress plays a role in the decrease in intestinal ZO-1 expression in infants”
    • Authors: Chiba , T. , Takaguri , A. , Kooka , A. , Wada
    • Year: 2022
  4. “Expression profiles of hsa-miR-148a-3p and hsa-miR-125b-5p in human breast milk and infant formulae”
    • Authors: Chiba, T., Kooka, A., Kowatari, K., Sato, H., Wada, S.
    • Year: 2022
  5. “Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab”
    • Authors: Chiba, T., Ujiie, H., Yaegashi, Y., Tasaki, Y., Sato, H.
    • Year: 2022
  6. “Analysis of risk factors for skin disorders caused by anti-epidermal growth factor receptor antibody drugs and examination of methods for their avoidance”
    • Or
    • Year: 2021
  7. “Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients”
    • Authors: Ujiie, H., Nihei, S., Nishiya, N., Chiba, T., Kudo, K.
    • Year: 2021
  8. “Norepinephrine transporter expressed on mammary epithelial cells incorporates norepinephrine in milk into the cells”
    • Authors: Chiba, T., Takaguri, A., Maeda, T.
    • Year: 2021
  9. “Physiologic changes in serotonin concentrations in breast milk during lactation”
    • Authors: Maeda, T., Shioyama, A., Tairabune, T., Kudo, K., Chiba, T.
    • Year: 2020
  10. “Cancer cachexia may hinder pain control when using fentanyl patch”
    • Authors: Chiba, T., Takahashi, H., Tairabune, T., Ueda, H., Kudo, K.
    • Year: 2020